Ilaris (Page 8 of 8)
PRINCIPAL DISPLAY PANEL
NDC 0078-0734-61
Rx only
ILARIS®
(canakinumab)Injection
150 mg/mL
For Subcutaneous Use
Single-Dose Vial. Discard Unused portion
Attention: Dispense with enclosed Medication Guide.
NOVARTIS
ILARIS canakinumab injection, solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Novartis Pharmaceuticals Corporation (002147023) |
Revised: 08/2023 Novartis Pharmaceuticals Corporation
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.